These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Synthesis and anti-HIV-1 activity of 1-substiuted 6-(3-cyanobenzoyl) and [(3-cyanophenyl)fluoromethyl]-5-ethyl-uracils. Loksha YM; Pedersen EB; Loddo R; La Colla P Arch Pharm (Weinheim); 2009 Sep; 342(9):501-6. PubMed ID: 19637180 [TBL] [Abstract][Full Text] [Related]
6. Non-nucleoside HIV reverse transcriptase inhibitors, Part 6[1]: synthesis and anti-HIV activity of novel 2-[(arylcarbonylmethyl)thio]-6-arylthio DABO analogues. Sun GF; Kuang YY; Chen FE; De Clercq E; Balzarini J; Pannecouque C Arch Pharm (Weinheim); 2005 Oct; 338(10):457-61. PubMed ID: 16211654 [TBL] [Abstract][Full Text] [Related]
7. The anti-HIV activity of three 2-alkylsulfanyl-6-benzyl-3, 4-dihydropyrimidin-4 (3H)-one derivatives acting as non-nucleoside reverse transcriptase inhibitor in vitro. Long J; Zhang DH; Zhang GH; Rao ZK; Wang YH; Tam SC; He YP; Zheng YT Yao Xue Xue Bao; 2010 Feb; 45(2):228-34. PubMed ID: 21348416 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and anti-HIV-1 activity of new fluoro-HEPT analogues: an investigation on fluoro versus hydroxy substituents. Loksha YM; Pedersen EB; Loddo R; La Colla P Arch Pharm (Weinheim); 2011 Jun; 344(6):366-71. PubMed ID: 21456073 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of 6-arylvinyl analogues of the HIV drugs SJ-3366 and Emivirine. Wamberg M; Pedersen EB; El-Brollosy NR; Nielsen C Bioorg Med Chem; 2004 Mar; 12(5):1141-9. PubMed ID: 14980626 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and anti-HIV-1 activity of 1-aromatic methyl-substituted 3-(3,5-dimethylbenzyl)uracil and N-3,5-dimethylbenzyl-substituted urea derivatives. Sakakibara N; Baba M; Okamoto M; Toyama M; Demizu Y; Misawa T; Kurihara M; Irie K; Kato Y; Maruyama T Antivir Chem Chemother; 2015 Feb; 24(1):3-18. PubMed ID: 26149262 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel uracil non-nucleoside derivatives as potential reverse transcriptase inhibitors of HIV-1. El-Brollosy NR; Al-Deeb OA; El-Emam AA; Pedersen EB; La Colla P; Collu G; Sanna G; Loddo R Arch Pharm (Weinheim); 2009 Nov; 342(11):663-70. PubMed ID: 19856332 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and anti-HIV-1 activity of new MKC-442 analogues with an alkynyl-substituted 6-benzyl group. Aly YL; Pedersen EB; La Colla P; Loddo R Arch Pharm (Weinheim); 2007 May; 340(5):225-35. PubMed ID: 17464964 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 6-substituted 5-alkyl-2-(phenylaminocarbonylmethylthio)pyrimidin-4(3H)-ones as potent HIV-1 NNRTIs. Yu M; Li Z; Liu S; Fan E; Pannecouque C; De Clercq E; Liu X ChemMedChem; 2011 May; 6(5):826-33. PubMed ID: 21322110 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and anti-HIV activity evaluation of 1-[(alkenyl or alkynyl or alkyloxy)methyl]-5-alkyl-6-(1-naphthoyl)-2,4-pyrimidinediones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors. Ji L; Chen FE; Xie B; De Clercq E; Balzarini J; Pannecouque C Eur J Med Chem; 2007 Feb; 42(2):198-204. PubMed ID: 17095124 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-HIV-1 activity evaluation of 5-alkyl-2-alkylthio-6-(arylcarbonyl or alpha-cyanoarylmethyl)-3,4-dihydropyrimidin-4(3H)-ones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors. Ji L; Chen FE; De Clercq E; Balzarini J; Pannecouque C J Med Chem; 2007 Apr; 50(8):1778-86. PubMed ID: 17381078 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors. Zhang J; Zhan P; Wu J; Li Z; Jiang Y; Ge W; Pannecouque C; De Clercq E; Liu X Bioorg Med Chem; 2011 Jul; 19(14):4366-76. PubMed ID: 21683601 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of 6-(3,5-dichlorobenzyl) derivatives as isosteric analogues of the HIV drug 6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-isopropyluracil (GCA-186). Sørensen ER; El-Brollosy NR; Jørgensen PT; Pedersen EB; Nielsen C Arch Pharm (Weinheim); 2005 Jul; 338(7):299-304. PubMed ID: 15996003 [TBL] [Abstract][Full Text] [Related]
18. Substrate-induced stable enzyme-inhibitor complex formation allows tight binding of novel 2-aminopyrimidin-4(3H)-ones to drug-resistant HIV-1 reverse transcriptase mutants. Samuele A; Facchini M; Rotili D; Mai A; Artico M; Armand-Ugón M; Esté JA; Maga G ChemMedChem; 2008 Sep; 3(9):1412-8. PubMed ID: 18465760 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-HIV-1 activity of novel 2,3-dihydro-7H-thiazolo[3,2-a]pyrimidin-7-ones. Danel K; Pedersen EB; Nielsen C J Med Chem; 1998 Jan; 41(2):191-8. PubMed ID: 9457243 [TBL] [Abstract][Full Text] [Related]
20. Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivatives. Ranise A; Spallarossa A; Cesarini S; Bondavalli F; Schenone S; Bruno O; Menozzi G; Fossa P; Mosti L; La Colla M; Sanna G; Murreddu M; Collu G; Busonera B; Marongiu ME; Pani A; La Colla P; Loddo R J Med Chem; 2005 Jun; 48(11):3858-73. PubMed ID: 15916438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]